We have identified a novel mouse member of the Wnt family, Wnt13. Among mouse Wnt genes, Wnt13 is most closely related to Wnt2. Sequence comparisons and chromosomal localization strongly suggest that Wnt13, rather than Wnt2, is the mouse orthologue of both the human WNT13 and Xenopus XWnt2 genes. Wnt13 is expressed in the embryonic mesoderm during gastrulation. At later stages, transcripts are detected in the dorsal midline of the diencephalon and mesencephalon, the heart primordia, the periphery of the lung bud and the otic and optic vesicles. These data suggest that Wnt13 function might partially overlap with those of other Wnt genes in the cell signaling mechanisms controlling mesoderm specification during gastrulation and some aspects of brain, heart and lung formation.
Introduction
The first vertebrate Wnt gene, Wnt1, was initially characterized more than 15 years ago as a proto-oncogene involved in the formation of mammary tumors in mouse. Since then, Wnt1 has been shown to belong to a much larger gene family, the Wnt family, which encodes secreted glycoproteins characterized by the presence of an amino-terminal signal sequence for secretion and the strong conservation of particular amino acid residues showing identical relative spacings within the protein (Nusse and Varmus, 1992) . Like wingless, the Drosophila orthologue of Wnt1, these genes have been shown to play a major part in cell signaling mechanisms controlling fundamental developmental processes and are also probably involved in some tumorigenesis events (Huguet et al., 1994; Parr and McMahon, 1994; Iozzo et al., 1995; Bui et al., 1997) . However, the complexity of the Wnt gene family makes it difficult to define orthology relationships and study functional conservation among the multiple vertebrate Wnt genes isolated thus far.
At least, 16 genes of the Wnt family have now been identified in mouse. They display unique, although largely overlapping expression patterns as early as gastrulation and, at later stages, in a number of different tissues including extraembryonic tissues, the central nervous system, the limb buds and the developing organs, lung, heart, kidney (Gavin et al., 1990; McMahon and McMahon, 1989; Roelink and Nusse, 1991; Parr et al., 1993; Stark et al., 1994; Bouillet et al., 1996) . In line with these complex embryonic expression patterns, Wnt genes have been shown to play a part in a variety of developmental processes including the midbrain and hindbrain development (McMahon and Bradley, 1990 ; Thomas and Capecchi, 1990) , somites and tailbud formation (Takada et al., 1994) , the early limb bud formation (Parr and McMahon, 1995) , the nephron development or the proper vascularization of the placenta (Monkley et al., 1996) .
However, in some cases, the complete absence of defects Sequence comparison between mWnt-13, hWnt-13 and Wnt-2 sub-family members. Amino-acid sequence alignment of mWnt-13, human Wnt-13 (hWnt-13) (Katoh et al., 1996) , Xenopus Wnt-2B (XWnt-2B) (Wolda and Moon, 1992) , partial Xenopus Wnt-2 (XWnt-2), mouse Wnt-2 (mWnt-2) (McMahon and McMahon, 1989) , rat Wnt-2 (rWnt-2) (Levay-Young and Navre, 1992) human Wnt-2 (hWnt-2) (Wainwright et al., 1988) and zebrafish Wnt-2 (ZWnt-2) (Blader et al., 1997) . Conserved amino acid residues are replaced by dashes and gaps were introduced to align the sequences. Black arrowheads show precise position of introns within the mWnt-13 protein sequence. (B) Phylogenetic tree showing sequence relationships between Wnt-2 related proteins. The branch lengths are proportional to the number of inferred substitutions.
in tissues where the gene is strongly expressed, suggests that functional redundancies might play a substantial part in the phenotypes observed. Thus, despite an early and strong expression in the developing heart and lung, Wnt2 mutant mice show no detectable defects in these tissues (Monkley et al., 1996) . The recent characterization of several additional Wnt2-related genes in other vertebrates, supports this possibility. While a single gene has been thus far isolated in rat (rWnt2; Levay-Young and Navre, 1992) and zebrafish (ZWnt2; Blader et al., 1997) , two Wnt2-related genes have been isolated both in Xenopus (XWnt2 and XWnt2b; Wolda and Moon, 1992; Landesman and Sokol, 1997) and in human (WNT2 and WNT13; Wainwright et al., 1988; Katoh et al., 1996) . The orthology relationships within this subfamily are not clear. However, XWnt2 appears much more related to WNT13 than to the human or murine Wnt2 genes, suggesting that they may be orthologous. We report here the cloning, chromosomal localization and expression of Wnt13, a murine gene orthologous to the human WNT13 gene. Rather than Wnt2, this new gene appears to be the mouse orthologue of XWnt2. Its expression pattern strongly suggests that his functions might overlap with those of Wnt2 in heart and lung development.
Results

Cloning of Wnt13, a novel mouse Wnt gene
A 384-bp fragment was obtained by RT-PCR from mouse 6.5-dpc embryo mRNAs, using degenerate primers corresponding to conserved peptidic motifs among the Wnt genes (Gavin et al., 1990) . The amino acid sequence deduced from its nucleotide sequence (Fig. 1A) showed that this fragment shares 96.1% amino-acid homology with the corresponding sequence of the recently cloned human WNT13 gene, suggesting that the cDNA fragment obtained may correspond to the mouse gene orthologous to the human WNT13 gene. In line with this hypothesis, the use of degenerate primers derived from the human WNT13 sequence led to the amplification of two additional 5′-and 3′-RT-PCR cDNA fragments, thus enabling assembly of a 964 nucleotides long partial cDNA (Fig. 1A) .
A recombinant phage was isolated from a 129/Sv mouse genomic library using this partial cDNA as a probe. Sequence analysis of this clone confirmed the partial cDNA sequence obtained by RT-PCR and showed that it is split into four exons (Fig. 1A,B) . Comparison of the deduced amino acid sequence to the human hWnt13 protein also showed that the strong homology previously observed could be extended up to the stop codon found at identical positions both in the mouse genomic sequence and human WNT13 cDNA sequence. By contrast, at the amino terminal end, the alignment is abruptly interrupted upstream from amino acid 42 of the human hWnt13 protein sequence, a position which is located immediately downstream from an intron acceptor site in the mouse genomic sequence. This suggests that the amino terminal part of the mouse protein is located in an additional upstream exon. An intron is also present at this position in vertebrate Wnt1 (van Ooyen and Nusse, 1984; van Ooyen et al., 1985) , Drosophila wingless (Rijsewijk et al., 1987) and mouse Wnt2 (McMahon and McMahon, 1989) .
The 5′ end of the Wnt13 cDNA, corresponding to the first exon of the gene, was obtained by PCR starting from mouse 7.0-dpc embryo cDNAs. The complete mWnt13 protein sequence thus identified is 390 amino acids long. It displays 24 cysteine residues which are characteristic for all Wnt proteins (Fig. 1A) .
Chromosomal localization of the mouse Wnt13 gene
The chromosomal localization of the mouse Wnt13 gene was achieved by matching the distribution pattern of conformational polymorphism of single stranded DNA (SSCP), amplified with primers as indicated in Section 4, with a series of molecular markers already mapped in the EUCIB (European Collaborative Interspecific Backcross) resource. This analysis indicated that Wnt13 maps to mouse chromosome 3, is very closely linked to the Tshb (thyroid stimulating hormone beta chain) locus (confidence interval between 0.00 and 0.72 centimorgans) (Fig. 1C ). This region is homologous to the 1p13 segment of human chromosome 1 where WNT13, the human counterpart of Wnt13 was found to map (Katoh et al., 1996) . 
Sequence relationships between vertebrate Wnt2, Wnt2b and Wnt13 proteins
A comparison of the mWnt13 coding sequence with other vertebrate Wnt2-related sequences is shown in Fig. 2A . Over the 332 terminal amino-acids, corresponding to exons 2, 3, 4 and 5, mWnt13 is most closely related to the human hWnt13 sequence (97.6% homology). It also shows a high homology to the Xenopus XWnt2b and the mouse, rat, human and zebrafish Wnt2 proteins (80.4, 71.1, 69.9, 69 and 62.6% homology, respectively).
In the first exon, a significant homology could also be observed between XWnt2b and mWnt13 upstream from the first intron donor site, with a 35 amino-acids insertion located immediately downstream from the initiation methionine in the mouse sequence ( Fig. 2A) . By contrast, the human and mouse Wnt13 sequences diverge extensively over the first exon. The human cDNA coding for hWnt13 was isolated from a gastric cancer cell line: whether alternative splicing mechanisms could account for this discrepancy, remains to be assessed.
A partial Xenopus XWnt2 cDNA sequence, termed XWnt2, has also been recently reported and is included in the comparison. The corresponding protein sequence appears substantially more related to mWnt13 and hWnt13 than to mWnt2 and hWnt2, suggesting that, as previously proposed, mouse Wnt13 and human WNT13, rather than mouse Wnt2 and human WNT2, are the mammalian orthologues of XWnt2. To add support to this possibility, sequence relationships between these different copies were examined using parsimony or distance matrices analyses. The resulting tree (Fig. 2B) confirms the close relationship between XWnt2, human WNT13 and mouse Wnt13 on the one hand, and the mammalian Wnt2 genes on the other hand, which define two clearly distinct classes. It also shows that the separation of the Xenopus XWnt2 and XWnt2b forms probably preceded the separation between amphibians and mammals suggesting that additional, Wnt2b-related, genes might be present in the mammalian genome. Finally, the branching order of the zebrafish ZWnt2 sequence suggests that a Xenopus gene, orthologous to the mammalian Wnt2 genes remains to be identified.
Expression of Wnt13 mRNA during embryogenesis
The expression pattern of Wnt13 mRNA was analyzed by whole-mount in situ hybridization of 6.5-9.5 dpc embryos and by in situ hybridization on cryostat sections of embryos from stages 9.5 and 10.5 dpc. Two different antisense RNA probes corresponding to nucleotides 331-849 and 882-1103 of the cDNA sequence, respectively (Fig. 1A) , were used. These two probes produced perfectly superimposable signals and showed no cross-hybridization with the mouse Wnt2 gene in genomic Southern blot analysis (data not shown).
Although the Wnt13 cDNA fragment had been isolated by RT-PCR starting from 6.5-dpc embryo mRNAs, no hybridization signal is detectable at this stage. Wnt13 expression is first visible during gastrulation at 7.0 dpc in the posterior part of the embryo where the primitive streak forms. From this stage up to 7.75 dpc, its expression extends anteriorly and laterally along with the primitive streak (Fig. 3A) . A parasagittal section through a 7.5-dpc embryo shows that Wnt13 mRNA is restricted to the mesodermal layer (Fig.  3B ). This first phase of expression is transient and Wnt13 expression appears down regulated at 8.0 dpc since we could not detect any transcript at this stage. At 8.5 dpc, before the turning of the embryo, Wnt13 signal is faintly visible in the anterior part of the embryo, at the level of the cephalic neural folds, as two stripes lining the neural groove. Another major site of expression is detected under the heart, at both sides of the foregut involution (Fig. 4A,B) .
After turning of the embryo, from 8.75 to 9.75 dpc, Wnt13 appears strongly expressed in the neuroepithelium of the developing brain, as a narrow line of expression in the dorsal midline (Fig. 4C,D) . This expression is restricted to the mesencephalon and the posterior part of the prosencephalon, with sharp anterior and posterior boundaries, and spreads laterally and ventrally at the boundary between the prosencephalon and mesencephalon. At 10.0 dpc, Wnt13 narrow line of expression in the dorsal brain is limited anteriorly by the telencephalic vesicles and posteriorly by the mesencephalon/rhombocephalon boundary (Fig. 4E) . Expression is also detected in the dorsal halves of the optic (inner and outer layer of optic cup) and otic (endolymphatic appendage of otic vesicle) vesicles (Fig. 4E,G-I) . In addition to the expression in the embryonic brain, a second major domain of expression can be observed in the vicinity of the heart (Fig. 4C-E) . In situ hybridizations on sagittal cryostat sections of 9.5-and 10.5-dpc embryos show that this site of expression is located at the level of the lung bud, spreading anteriorly around the pericardio-peritoneal canal and posteriorly in the peritoneal cavity (Fig. 5A-C) . However, with the exception of the signal at the periphery of the lung bud, stained cells do not belong to a precise morphological structure. This staining may correspond to cells that will form the lung itself or that surround it. No Wnt13 expression was detected in the limb buds, where several Wnt genes are known to be transcribed (Parr et al., 1993) .
Discussion
Orthology relationships between vertebrate Wnt2-related genes
We report here the structural characterization and embryonic expression pattern of Wnt13, a novel mouse gene belonging to the Wnt family. This gene appears most closely related to the Wnt2 subgroup of this large family which comprises at least 16 members thus far identified in mouse. However, several lines of evidence strongly suggest that mouse Wnt13, human WNT13 and xenopus XWnt2 define an orthology group which is distinct from the one comprising mouse Wnt2, human WNT2 and rat rWnt2. First, the corresponding protein sequences are closely related, showing a number of differences selectively maintained with Wnt2 genes identified in mammals. Second, the chromosomal localization of Wnt13 and WNT13 on homologous chromosomal loci in mouse and human adds further support to the orthology relationship proposed between these genes. In mammals, Wnt genes are dispersed throughout the genome (Nusse and Varmus, 1992) and the chromosomal assignment of WNT13 and Wnt13 is distinct from the one displayed by Wnt2 and WNT2, which belong to a syntenic group between mouse chromosome 6 and human 7q (Wainwright et al., 1988; McMahon and McMahon, 1989) . Finally, although the comparison of embryonic expression patterns between these three genes remains difficult due to the absence of detailed expression studies of WNT13 and XWnt2, several common features are suggested by the available data. Northern blot analyses of human fetal tissues have shown that like mouse Wnt13, human WNT13 is expressed in the developing brain and the developing lung. By contrast, no Wnt2 expression has been thus far reported in the developing brain, either in mouse, rat or human.
Characterization of another Wnt2-related gene, XWnt2b, has been recently reported in Xenopus. This gene also displays an embryonic brain expression domain, located at the prosencephalic-mesencephalic boundary at the neurula stage (Landesman and Sokol, 1997) . As inferred from the sequence relationships analysis, it might define a third orthology group within vertebrate Wnt2-related genes. Although gene losses cannot be excluded, this raises the possibility that additional, yet unidentified Wnt2-related genes, might exist in mouse.
Wnt13 embryonic expression pattern: comparison with other mouse Wnt genes
The presence of several copies of Wnt2-related genes in mouse raises the possibility of functional gene redundancies, which should be taken into account in the interpretation of the corresponding mutant phenotypes. At 8.0 dpc, both Wnt13 and Wnt2 are expressed in cells surrounding the foregut involution, an area associated with early heart development. This signal, located posteriorly to the heart, is also conserved until 10.5 dpc for both genes (Monkley et al., 1996) . Likewise, at 10.5 dpc, Wnt13 and Wnt2 transcripts are detected in the periphery of the lung bud (Bellusci et al., 1996) . The absence of phenotype of Wnt2 mutant mice in the developing brain and lung, where the gene is strongly expressed, might therefore be due to gene compensation by Wnt13. No Wnt2 expression was observed in the two other major sites of Wnt13 expression, the ingressing mesoderm during gastrulation and the embryonic brain.
During gastrulation, four other mouse Wnt genes have been reported to be expressed in the primitive streak and ingressing mesoderm: Wnt8 (Bouillet et al., 1996) , Wnt3a, Wnt5a and Wnt5b (Takada et al., 1994) . From early to late egg cylinder stages, Wnt5a and Wnt5b transcription is mostly restricted to the posterior part of the primitive streak, fated to extraembryonic mesoderm. By 7.5 dpc, transcripts are also detected in the developing allantois. At this stage, Wnt3a and Wnt8 expression is more widespread and extends along the whole length of the primitive streak, both in the ectoderm and the mesoderm layers. These expression domains are not perfectly superimposable, Wnt8 transcripts extending beyond those of Wnt3a towards lateral and rostral regions of the ectoderm. Wnt13 expression domain, which spans the whole length of the primitive streak, largely overlaps those of Wnt8, Wnt3a, Wnt5a and Wnt5b at 7.5 dpc. However, it also displays several distinctive features. No expression was detected in the extraembryonic mesoderm, and in the primitive streak, the signal was always restricted to the mesoderm layer. Furthermore, the proximal and lateral expression of Wnt13 in the migrating mesodermal wings is not shared by any other Wnt gene.
While its transcription level remains low up to 7.5 dpc, Wnt3a, like Wnt5a and Wnt5b, shows a strong expression at later stages of gastrulation, in the regressing primitive streak and, by 8.0 dpc, in the tail bud. By contrast, Wnt13, like Wnt8, is expressed at earlier stages of gastrulation, up to 7.5 dpc, but is undetectable in the tail bud at 8.0 dpc. The Wnt3a −/− mutant phenotype is characterized by the absence of tail bud, the loss of somites and disruption of the notochord specifically in posterior regions of the embryo, caudal to the forelimb level. The distinct temporal expression patterns displayed by Wnt13 and Wnt3a suggest that Wnt13 could be involved in the specification of mesodermal subtypes which are unaffected by Wnt3a inactivation, like ventral or anterior mesoderm. At later stages of development, in the embryonic brain, an expression of Wnt13 was also detected, restricted at 9.5 dpc to the diencephalon and the dorsal midline of the mesencephalon. At these stages, many members of the Wnt family show overlapping although non-identical expression domains, in specific subregions of the embryonic brain (Roelink and Nusse, 1991; Parr et al., 1993) . The role of Wnt1 in the specification of the midbrain and part of the dorsal, rostral hindbrain has also been demonstrated by inactivation in mice (McMahon and Bradley, 1990; Thomas and Capecchi, 1990) . Wnt13 shares common expression features with several other mouse Wnt genes. However, none of these expression patterns are perfectly superimposable. In the diencephalon, like Wnt3, Wnt3a and Wnt7b, Wnt13 displays a dorsal and lateral domain of expression. However, Wnt3a and Wnt7b expression domains which span a broader, triangular patch of cells, are distinct from the one displayed by Wnt13. In both of these cases, an extension of this expression is also observed in the dorsal midline of the telencephalon, where no Wnt13 expression is detectable. In the mesencephalon, expressions of Wnt1, Wnt3, Wnt3a and Wnt7b have been reported. However, the boundaries of these exuression domains are different from those displayed by Wnt13: Wnt3 and Wnt3a expression extends more posteriorly into the hindbrain and spinal cord, while Wnt7b is only expressed in a limited region, anterior to the mesencephalon/metencephalon junction. Likewise, a sharp posterior boundary of expression at the midbrain/ hindbrain junction is common to Wnt1 and Wnt13, but Wnt1 expression spreads laterally and ventrally while Wnt13 transcription is restricted to the midline.
Systematic functional analyses by inactivation in mice will be necessary to clarify the respective roles of Wnt13 and other Wnt genes in mesoderm specification or embryonic brain patterning. In addition, WNT13 has been shown to be expressed in various human cancer cell lines, suggesting a possible involvement in human carcinogenesis (Katoh et al., 1996) . Generation of Wnt13 null mutant mice might help to derive animal models for these pathologies.
Experimental procedures
cDNA cloning and sequencing
A 384-bp partial cDNA fragment was obtained by RT-PCR starting from 6.5-dpc mRNAs isolated using the QuickPrep micro mRNA purification kit from Pharmacia. First strand cDNA was synthesized with RT superscript II from BRL and random hexamers. The cDNA was then amplified by PCR in the presence of degenerate primers as previously described (Gavin et al., 1990) corresponding to the 5′-QECKCH and 3′-FHWCC peptidic motives. Additional 5′-and 3′-Wnt13 sequences were obtained by RT-PCR using two sets of primers. For the 5′ fragment: W13-5′-GTNATHTGYGAYAAYAT and W2a-5N AGA-GTACAGGAGCCACTCACG and for the 3′ fragment: W13-3′-GTYTGRTCNARCCAYTC and W2a-3N GCC-GAGGGTATGACACAACTCG. The genomic clone was obtained after screening a Lambda Dash II 129/Sv mouse genomic library and sequencing was performed manually on the cDNA and genomic DNA with the sequenase Version 2.0 DNA Sequencing Kit from USB. A DNA homology search was done using the BLAST network. The 5′ end of the cDNA was isolated by PCR starting from a mouse 7-dpc embryo Marathon ready cDNA library from Clontech using the primers AP1, AP2 (provided by the manufacturer) and W2a-G GGGATGTTGTCACAGATCACTACTCGG.
Chromosomal localization of Wnt13
SSCP analysis of two 112 and 165 nucleotides long DNA fragments, resulting from PCR amplification with two sets of primers from exons 2 (W2a-M GTGATCTGTGACAA-CATC and W2a-W CACTCTCGGATCCATTCCCG) and 4 (W2a-3 CGTCTGCAGCAAGACTTCTAAAGGA and W2a-O GTGTGGACATCCACAGTG) of Wnt13 gene, respectively, revealed polymorphism between Mus spretus and C57BL/6 strains. Wnt13 was mapped by matching the pattern of distribution of these polymorphisms to those already stored in our database for the DNA of the EUCIB resource (European Collaborative Interspecific Backcross; Breen, 1994) . Haplotype analyses were performed using the GeneLink program (Montagutelli, 1990) .
Sequence relationships analysis
Phylogenetic analyses of the protein sequences were performed using the program from the Phylip computer package. Protein distance matrices were generated using the Protdist program and neighboring trees calculated using the Neighbor program.
In situ hybridizations
1. The Wnt13a antisense RNA probe was synthesized with digoxigenin 11-UTP from Boehringer Mannheim. 2. In situ hybridizations on cryostat sections were performed as described by Myat et al. (1996) with the following modifications. After the overnight fixation embryos were left to settle in 15% sucrose, then incubated in 15% sucrose 7% gelatine at 37°C and finally embedded in Tissue-Tek OCT (Sakura). Blocks were conserved at −80°C and cryostat sections were transferred to SuperFrost/Plus (Menzel Glaser) slides. We used anti-Digoxigenin-AP Fab fragments and the BM Purple Substrate from Boehringer Mannheim for the staining reaction. Slides were mounted in Mowiol (Calbiochem). 3. Whole-mount in situ hybridizations were performed as described by Henrique et al. (1995) . Embryos were photographed in 50% glycerol in PBT.
